142 related articles for article (PubMed ID: 3611358)
21. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
[TBL] [Abstract][Full Text] [Related]
22. Effects of chenodeoxycholic acid and deoxycholic acid on cholesterol absorption and metabolism in humans.
Wang Y; Jones PJ; Woollett LA; Buckley DD; Yao L; Granholm NA; Tolley EA; Heubi JE
Transl Res; 2006 Jul; 148(1):37-45. PubMed ID: 16887497
[TBL] [Abstract][Full Text] [Related]
23. Cholesterol absorption efficiency regulates plasma cholesterol level in the Finnish population.
Kesäniemi YA; Miettinen TA
Eur J Clin Invest; 1987 Oct; 17(5):391-5. PubMed ID: 3121341
[TBL] [Abstract][Full Text] [Related]
24. Impact of apo E phenotype on the regulation of cholesterol metabolism.
Miettinen TA
Ann Med; 1991 Apr; 23(2):181-6. PubMed ID: 2069794
[TBL] [Abstract][Full Text] [Related]
25. Cholesterol absorption and metabolism and LDL kinetics in healthy men with different apoprotein E phenotypes and apoprotein B Xba I and LDL receptor Pvu II genotypes.
Gylling H; Kontula K; Miettinen TA
Arterioscler Thromb Vasc Biol; 1995 Feb; 15(2):208-13. PubMed ID: 7749827
[TBL] [Abstract][Full Text] [Related]
26. [Tokyo Centenarian Study. 4. Apolipoprotein E phenotype in Japanese centenarians living in the Tokyo Metropolitan area].
Hirose N; Homma S; Arai Y; Kawamura M; Hasegawa H; Ishida H; Shimizu K; Osono Y; Homma A; Nakamura Y
Nihon Ronen Igakkai Zasshi; 1997 Apr; 34(4):267-72. PubMed ID: 9212680
[TBL] [Abstract][Full Text] [Related]
27. Pharmacologic modulation of the low density lipoprotein receptor pathway.
Shepherd J; Packard CJ
Prog Clin Biol Res; 1988; 255():265-71. PubMed ID: 3277199
[No Abstract] [Full Text] [Related]
28. Genetic variation in human apolipoprotein E.
Wardell MR; Suckling PA; Janus ED
J Lipid Res; 1982 Nov; 23(8):1174-82. PubMed ID: 7175374
[TBL] [Abstract][Full Text] [Related]
29. The effects of amoxicillin and vancomycin on parameters reflecting cholesterol metabolism.
Baumgartner S; Reijnders D; Konings MCJM; Groen AK; Lütjohann D; Goossens GH; Blaak EE; Plat J
Chem Phys Lipids; 2017 Oct; 207(Pt B):239-245. PubMed ID: 28647339
[TBL] [Abstract][Full Text] [Related]
30. Cholesterol absorption, elimination and synthesis in coeliac disease.
Vuoristo M; Miettinen TA
Eur J Clin Invest; 1982 Aug; 12(4):285-91. PubMed ID: 6814919
[TBL] [Abstract][Full Text] [Related]
31. [Diet therapy of hyperlipidemia].
Yamada N
Nihon Rinsho; 1990 Nov; 48(11):2605-12. PubMed ID: 2270028
[No Abstract] [Full Text] [Related]
32. Apolipoprotein E-induced cell signaling in the vessel wall.
Hui DY
Rev Endocr Metab Disord; 2004 Dec; 5(4):335-41. PubMed ID: 15486466
[No Abstract] [Full Text] [Related]
33. [Analysis of apoE phenotype and its clinical significance].
Tamasawa N; Suda T
Nihon Rinsho; 2007 Jul; 65 Suppl 7():218-23. PubMed ID: 17821897
[No Abstract] [Full Text] [Related]
34. Serum cholesterol response to dietary cholesterol and apoprotein E phenotype.
Miettinen TA; Gylling H; Vanhanen H
Lancet; 1988 Nov; 2(8622):1261. PubMed ID: 2903999
[No Abstract] [Full Text] [Related]
35. Lipid metabolism.
Giddings JC
Curr Opin Lipidol; 1997 Aug; 8(4):U51-3. PubMed ID: 9253545
[No Abstract] [Full Text] [Related]
36. ApoE isoform-related behavioral defects. Is chronic cholesterol loss-driven membrane disorganization behind?
Abad-Rodríguez J
Exp Neurol; 2013 Mar; 241():1-4. PubMed ID: 23262123
[No Abstract] [Full Text] [Related]
37. HDL and innate immunity: a tale of two apolipoproteins.
Grunfeld C; Feingold KR
J Lipid Res; 2008 Aug; 49(8):1605-6. PubMed ID: 18515886
[No Abstract] [Full Text] [Related]
38. Apolipoprotein E phenotype and blood pressure.
Uusitupa M; Sarkkinen E; Kervinen K; Kesäniemi YA
Lancet; 1994 Jan; 343(8888):57. PubMed ID: 7905068
[No Abstract] [Full Text] [Related]
39. [Cholesterol absorption, synthesis markers and coronary heart disease].
Li ZZ; Wang LY; Yu ZQ
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Sep; 37(9):857-9. PubMed ID: 20128389
[No Abstract] [Full Text] [Related]
40. Location, location, location...again.
Patel SB
J Lipid Res; 2011 Mar; 52(3):417-8. PubMed ID: 21205705
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
